Skip to main navigation Products Investors News Careers Contact SIGA: Human BioArmor MENU Press Releases YEAR 2021 Nov 16, 2021 European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat Nov 04, 2021 SIGA Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2021 Oct 28, 2021 SIGA Technologies to Host Business Update Call on November 4th, 2021, Following Release of Third Quarter 2021 Financial Results Sep 13, 2021 SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX® Sep 07, 2021 SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021 Aug 05, 2021 SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021 Jul 29, 2021 SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results Jul 29, 2021 SIGA Announces Collaboration with Oxford University to Support Expanded Access Protocol for Use of TPOXX® (Tecovirimat) To Treat Monkeypox in Central African Republic Jun 30, 2021 SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom Jun 10, 2021 SIGA’s CEO, Dr. Phillip Gomez, and Garrett Ingram, President, CEO of Cipla Therapeutics, discuss the companies’ recently announced collaboration to provide the U.S. government with solutions for its biothreat and public health needs, with a focus on tackling antimicrobial resistance Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 18 Shareholder Tools Print Email Alerts RSS News Feeds Contact IR SIGA: Human BioArmor Corporate Headquarters 31 East 62nd Street New York, NY 10065 (212) 672-9100 SIGA Development Operations 4575 SW Research Way, Suite 110 Corvallis, OR 97333 (541) 753-2000 Privacy Notice © 2021 SIGA Technologies, All Rights Reserved By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies